As of 2024-12-12, the Fair Value of E-Therapeutics PLC (ETX.L) is -6.60 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.00 GBP, the upside of E-Therapeutics PLC is -173.37%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 5Y Avg | |
| Net income | -4.00 | -2.35 | -3.68 | -8.07 | -8.27 | -5.27 |
| YoY growth | 25.38% | 41.31% | -56.97% | -119.06% | -2.53% | -22.37% |
| Market Cap (mil) | 56.39 |
| P/E | |
| Forward P/E |
| EPS | -1.32 |
| Avg earnings growth rate | -22.37% |
| TTM earnings | -8.27 |